Scarlet Fever Epidemic, Hong Kong, 2011

More than 900 cases of scarlet fever were recorded in Hong Kong during January–July, 2011. Six cases were complicated by toxic shock syndrome, of which 2 were fatal. Pulsed-field gel electrophoresis patterns suggested a multiclonal epidemic; emm12 was the predominant circulating type. We recommend genetic testing of and antimicrobial resistance monitoring for this reportable disease.

More than 900 cases of scarlet fever were recorded in Hong Kong during January-July, 2011. Six cases were complicated by toxic shock syndrome, of which 2 were fatal. Pulsed-fi eld gel electrophoresis patterns suggested a multiclonal epidemic; emm12 was the predominant circulating type. We recommend genetic testing of and antimicrobial resistance monitoring for this reportable disease.
S carlet fever is caused by infection with Streptococcus pyogenes and mainly affects children. An upsurge of scarlet fever occurred in Hong Kong, People's Republic of China, in 2011, exceeding baseline annual incidence rates for the previous 2 decades. We investigated possible changes in clinical severity, transmissibility, and characteristics of the causative pathogen for this outbreak.

The Study
Scarlet fever is a statutory notifi able disease in Hong Kong. A clinical case is defi ned as illness in a person who has clinical features of scarlet fever (fever and fi ne, sandpaper rash of characteristic distribution that blanches on pressure, with or without strawberry tongue, desquamation, or sore throat). A confi rmed case is defi ned as a clinical case with positive throat or wound culture for S. pyogenes or antistreptolysin titer >200.
Epidemiologic, clinical, and laboratory data were collected by standard questionnaire for every reported case. A cluster was defi ned as >2 cases in persons sharing the same residential or school address within the incubation period. We compared epidemiologic, clinical, and microbiological features of the scarlet fever cases from January-July 2011 (outbreak period) with features of those reported during 2008-2010 (baseline period). We used SPSS version 14.0 (SPSS Inc., Chicago, IL, USA) for analyses; p<0.05 was considered signifi cant.
For comparison, we performed a retrospective review of hospital discharge records kept by public hospitals. We extracted records of patients hospitalized during January 2008-July 2011 who had diagnoses that are known complications of scarlet fever, including toxic shock syndrome, acute rheumatic fever, and acute glomerulonephritis. These cases were reviewed to determine whether the complications were related to scarlet fever.
Bacterial culture of S. pyogenes was performed on diagnostic specimens in hospital laboratories and the Public Health Laboratory Centre of the Department of Health; the latter serves as the diagnostic and public health reference laboratory in Hong Kong. Antimicrobial drug susceptibility testing, emm typing, and detection of various virulence genes were performed at the Public Health Laboratory Centre on S. pyogenes isolates received during 2011 and archived during 2008-2010 (1). Pulsed-fi eld gel electrophoresis (PFGE) was performed on the basis of the gram-positive protocol, and PFGE profi les were analyzed by using BioNumerics 5.0 software (Applied Maths, Sint-Martens-Latem, Belgium).
In June 2011, the Department of Microbiology of the University of Hong Kong announced the discovery of a unique 48-kb insertion sequence in the genome of S. pyogenes isolated from a blood specimen from a 7-year-old girl who died of scarlet fever (2). We tested for this insert in a sample of strains collected during 2008-2011 using the method provided by the University of Hong Kong.
During January 1-July 31, 2011, a total of 996 cases of scarlet fever were reported, greatly exceeding the annual number of cases reported during 2008 (235), 2009 (187), and 2010 (128). Outbreak activity in 2011 peaked at week 26 (week ending June 25) ( Figure 1). During the outbreak period (January-July 2011), the annualized incidence rate was 24.0/100,000 population, ≈9× higher than the average annualized incidence rate of 2.62/100,000 population during the baseline period of 2008-2010. During the previous 2 decades, baseline annual incidence rates ranged from 0.0351 to 3.37 cases/100,000 population. Table 1 compares the epidemiologic features, clinical features, and laboratory results for scarlet fever cases reported during 2011 and 2008-2010. Highest incidence (547 cases/100,000 population) was reported for children 4-7 years of age (Table 1). Clinical features, complications, and case-fatality rate for cases reported in 2011 were largely comparable to those reported during the baseline period. The proportion of case-patients requiring hospitalization during 2011 was lower, and mean duration of hospital stay was ≈0.5 days shorter than for the baseline period. Details of the 9 complicated cases are shown in Table 2.
Among the 996 scarlet fever cases reported during January-July 2011, S. pyogenes isolates from samples Forty-eight emm12 isolates during January-June 2011 that were subjected to virulence gene profi ling showed 5 virulence gene profi les. No particular virulence gene profi le was dominant among the 9 scarlet fever cases associated with medical complications ( Table 2). Among 26 emm12 strains subjected to PFGE, 7 patterns were detected; the emm12 strain from 1 of the 2 fatal cases exhibited a unique PFGE pattern (Figure 2). For the other fatal case, an emm1 strain positive for speA was isolated.

Conclusions
The 2011 S. pyogenes outbreak in Hong Kong attracted heightened media coverage, which might have increased reporting of cases; however, the higher proportion of laboratory-confi rmed cases in 2011 than those during 2008-2010 suggests the upsurge was genuine. Overall clinical and epidemiologic profi les in 2011 did not differ from previous years. We found insuffi cient evidence that a particular emm type of virulence gene profi le or presence of the 48-kb insert was associated with increased incidence or severity.
The reasons for the upsurge remain obscure.  years (20%-30%) (4). Because all erythromycin-resistant strains were also resistant to clindamycin (data not shown), we deduced the resistance mechanism to be resistance to macrolides, lincosamides, and streptogramins B system, as encoded by the erm genes (5).
The 48-kb insert provided a mechanism for macrolide resistance among S. pyogenes in Hong Kong, but our laboratory investigation found macrolide-resistant S. pyogenes strains and the macrolide-susceptible strains that bore them negative for this insert. Mutation of the PCR primer binding site might explain the former strains; further investigation is needed to explore this possibility.
The upsurge in scarlet fever cases in Hong Kong during 2011 likely refl ects a regional phenomenon; a marked increase in cases was also observed in mainland China (6) and Macao (7) during this period. High resistance rates against macrolides were also observed for the outbreak in mainland China (8). We recommend close monitoring and surveillance of disease activity, genetic testing, antimicrobial susceptibility profi ling, and maintaining scarlet fever's statutory notifi able status.